Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fractyl Health, Inc. - Common Stock (NQ: GUTS )

2.060 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 209,299
Open 2.080
Bid (Size) 2.060 (10)
Ask (Size) 2.240 (10)
Prev. Close 2.060
Today's Range 2.010 - 2.190
52wk Range 1.740 - 14.50
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates
From Fractyl Health, Inc.
Via GlobeNewswire
Earnings Scheduled For November 12, 2024
Via Benzinga

Performance

YTD
-83.97%
-83.97%
1 Month
-21.67%
-21.67%
3 Month
-29.21%
-29.21%
6 Month
-72.75%
-72.75%
1 Year
-83.97%
-83.97%

More News

Read More
Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024
From Fractyl Health, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health to Participate in Upcoming September Investor Conferences
From Fractyl Health, Inc.
Via GlobeNewswire
GUTS Stock Earnings: Fractyl Health Beats EPS for Q2 2024
Via InvestorPlace
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Association’s
From Fractyl Health, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
From Fractyl Health, Inc.
Via GlobeNewswire
GUTS Stock Earnings: Fractyl Health Beats EPS for Q1 2024
Via InvestorPlace
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
From Fractyl Health, Inc.
Via GlobeNewswire
Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
From Fractyl Health, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.